Skip to main content

Table 3 Lipid profile changes of the Yerba Mate and placebo groups at 0, 6 and 12 weeks

From: Anti-obesity effects of Yerba Mate (Ilex Paraguariensis): a randomized, double-blind, placebo-controlled clinical trial

 

Yerba Mate (n = 15)

Placebo (n = 15)

P value1)

 

0 weeks

6 weeks

12 weeks

P value1)

0 weeks

6 weeks

12 weeks

P value1)

Total cholesterol (mg/dL)

193.6 ± 24.8

197.9 ± 33.2

204.4 ± 36.0

0.384

176.7 ± 28.8

172.3 ± 33.9

174.0 ± 28.4

0.977

0.722

HDL-cholesterol (mg/dL)

45.4 ± 7.7

48.0 ± 10.3

48.2 ± 10.1

0.424

52.3 ± 12.0

50.4 ± 8.3

48.0 ± 8.3

0.369

0.223

LDL-cholesterol (mg/dL)

120.9 ± 27.5

117.8 ± 28.8

121.7 ± 34.6

0.755

101.7 ± 25.6

97.2 ± 27.5

96.7 ± 30.8

0.944

0.862

Triglyceride (mg/dL)

141.5 ± 79.9

130.6 ± 96.3

154.2 ± 96.6

0.325

123.1 ± 65.8

107.2 ± 53.8

127.5 ± 95.1

0.548

0.969

Free Fatty Acid (μEq/L)

516.6 ± 163.6

412.2 ± 128.8

443.5 ± 169.7

0.234

541.5 ± 337.3

541.5 ± 225.6

575.3 ± 220.1

0.286

0.224

  1. Values are presented as the mean ± S.D
  2. 1) Analyzed by repeated measures ANOVA